Could GLP-1 drugs help breast cancer patients live longer?

	Breast Cancer
	The latest breast cancer news from News Medical

	Could GLP-1 drugs help breast cancer patients live longer? A large retrospective cohort study of adult female breast cancer patients found that GLP-1 receptor agonist use was associated with better all-cause survival and recurrence-free survival in patients with obesity or type 2 diabetes. The strongest associations were seen versus non-use in obesity and versus insulin or metformin in type 2 diabetes, while comparisons with SGLT2 inhibitors were less consistent and require further study.

	New study reveals how slow-growing cells drive breast cancer relapse A new study by the Garvan Institute of Medical Research has uncovered a hidden mechanism explaining why breast cancer can return many years after successful treatment.

	Gene panel predicts chemotherapy response in triple-negative breast cancer Researchers at The University of Texas MD Anderson Cancer Center have characterized cancer cell-specific features in the tumor microenvironment (TME) of early-stage triple-negative breast cancer (TNBC) tissues, identifying specific macrophage subtypes associated with chemotherapy response.

			Researchers develop pH and redox-sensitive systems to reduce immunotherapy toxicity Although cancer immunotherapy has transformed treatment by harnessing the immune system to eliminate tumors, only a small subset of patients benefit. Many solid tumors remain "cold," characterized by poor immune cell infiltration and resistance to immune checkpoint blockade (ICB).

			Study reveals why aging makes the body more vulnerable to breast cancer Researchers at Georgetown's Lombardi Comprehensive Cancer Center have identified a mechanism that may help explain a key reason why older people experience worse outcomes from breast cancer.

			Targeted radiotherapy may delay progression in metastatic breast cancer patients Treating breast cancer that has begun to spread around the body with targeted radiotherapy could help patients to live longer without their cancer getting worse, according to the results of a small randomised controlled trial presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026).

	How nanoparticles could help immunotherapy turn cold tumors hot Engineered nanoparticles can improve cancer immunotherapy by delivering drugs, antigens, and genetic payloads with greater precision while remodeling the tumor microenvironment. The review highlights how nano-immunotherapy could boost immune activation, improve checkpoint-blockade responses, and support more personalized cancer treatment, although safety, scalability, and clinical translation challenges remain.

	Adult weight gain strongly linked to higher obesity-related cancer risk New research presented at this year's European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows that people who gain the highest amount of weight across adulthood are at greatly increased risk of certain obesity related cancers.

	Cedars-Sinai develops AI tool for faster and cheaper tumor analysis A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes expressed in cancerous tumors.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026